Page last updated: 2024-09-03

mk 0663 and Hematochezia

mk 0663 has been researched along with Hematochezia in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cannon, CP; Cryer, B; Curtis, SP; Jensen, DM; Kaur, A; Laine, L; Langman, M	1
Bowen, B; Callegari, P; Evans, J; Harper, S; Hunt, RH; James, C; Quan, H; Rashid, F; Yu, C	1
Evans, JK; Harper, S; Hunt, RH; Lee, M; Oxenius, B; Quan, H; Watson, DJ; Yu, C	1
Bolognese, JA; Curtis, SP; Ramey, DR; Reicin, AS; Watson, DJ; Yu, C	1
Psaty, BM; Weiss, NS	1
Cannon, CP; Cryer, B; Curtis, SP; Kaur, A; Laine, L	1
Parashar, A	1
Baraf, HS	1

Reviews

3 review(s) available for mk 0663 and Hematochezia

Article	Year
The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis. Current medical research and opinion, 2005, Volume: 21, Issue:5 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Etoricoxib; Gastrointestinal Hemorrhage; Gastrointestinal Tract; Humans; Incidence; Intestinal Perforation; Peptic Ulcer; Proportional Hazards Models; Pyridines; Randomized Controlled Trials as Topic; Sulfones	2005
Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet (London, England), 2007, Feb-10, Volume: 369, Issue:9560 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; Aspirin; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Etoricoxib; Female; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Osteoarthritis; Peptic Ulcer; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Pyridines; Sulfones	2007
Efficacy of the newest COX-2 selective inhibitors in rheumatic disease. Current pharmaceutical design, 2007, Volume: 13, Issue:22 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Arthritis, Rheumatoid; Cardiovascular Diseases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Gastrointestinal Hemorrhage; Humans; Membrane Proteins; Osteoarthritis; Patient Selection; Pyridines; Rheumatic Diseases; Risk Assessment; Risk Factors; Spondylitis, Ankylosing; Sulfones	2007

Trials

3 trial(s) available for mk 0663 and Hematochezia

Article	Year
Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac. Gastroenterology, 2008, Volume: 135, Issue:5 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Confidence Intervals; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Etoricoxib; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Incidence; Male; Middle Aged; Odds Ratio; Osteoarthritis; Prospective Studies; Pyridines; Risk Factors; Sulfones; Treatment Outcome	2008
Complementary studies of the gastrointestinal safety of the cyclo-oxygenase-2-selective inhibitor etoricoxib. Alimentary pharmacology & therapeutics, 2003, Volume: 17, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Duodenal Ulcer; Etoricoxib; Female; Gastrointestinal Hemorrhage; Humans; Ibuprofen; Isoenzymes; Male; Membrane Proteins; Middle Aged; Occult Blood; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Pyridines; Stomach Ulcer; Sulfones	2003
The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. The American journal of gastroenterology, 2003, Volume: 98, Issue:8 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Endoscopy; Etoricoxib; Female; Gastrointestinal Hemorrhage; Humans; Ibuprofen; Incidence; Isoenzymes; Male; Membrane Proteins; Meta-Analysis as Topic; Middle Aged; Peptic Ulcer; Peptic Ulcer Perforation; Prostaglandin-Endoperoxide Synthases; Pyridines; Sulfones; Treatment Outcome	2003

Other Studies

2 other study(ies) available for mk 0663 and Hematochezia

Article	Year
NSAID trials and the choice of comparators--questions of public health importance. The New England journal of medicine, 2007, Jan-25, Volume: 356, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Clinical Trials, Phase IV as Topic; Cyclooxygenase 2 Inhibitors; Diclofenac; Drug Approval; Drug Industry; Etoricoxib; Gastrointestinal Hemorrhage; Humans; Pyridines; Sulfones; United States; United States Food and Drug Administration	2007
Gastrointestinal safety of NSAIDs versus COX-2 inhibitors. Lancet (London, England), 2007, Apr-21, Volume: 369, Issue:9570 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Diclofenac; Etoricoxib; Gastrointestinal Hemorrhage; Humans; Peptic Ulcer; Pyridines; Sulfones	2007

Article

Year

NSAID trials and the choice of comparators--questions of public health importance.

The New England journal of medicine, 2007, Jan-25, Volume: 356, Issue:4

Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Clinical Trials, Phase IV as Topic; Cyclooxygenase 2 Inhibitors; Diclofenac; Drug Approval; Drug Industry; Etoricoxib; Gastrointestinal Hemorrhage; Humans; Pyridines; Sulfones; United States; United States Food and Drug Administration

2007

Gastrointestinal safety of NSAIDs versus COX-2 inhibitors.

Lancet (London, England), 2007, Apr-21, Volume: 369, Issue:9570

Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Diclofenac; Etoricoxib; Gastrointestinal Hemorrhage; Humans; Peptic Ulcer; Pyridines; Sulfones

2007